This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
EPR Issue 2 includes articles on the impact of tariffs on the pharmaceutical supply chain, advances in bioprocessing, the potential of digital twins in manufacturing, cell and gene therapies and more. Included in this issue of European Pharmaceutical Review : FOREWORD Setting rationale specifications for early-phase non-mutagenic impurities David Elder David P Elder Consultancy SUPPLY CHAIN Tariff risks and opportunities for pharma manufacturers Clifford Rossi, PhD, University of Maryland IN-D
Over the last five years, health systems, medical societies, and their clinicians have been working to unravel the role of race in clinical practice. After clinical algorithms that use race as a variable came under scrutiny in 2020, several commonly used tools have been revised to align with medicine’s understanding that race is not a biological construct, but a social one.
Nearly eight million doses of illegal medicines have been seized by the Medicines and Healthcare products Regulatory Agency (MHRA) in an operation to tackle the illegal online sale of medicines and medical devices, the regulator has said. Working with law enforcement partners between December 2024 and May 2025, the MHRA’s Criminal Enforcement Unit (CEU) seized […] The post Estimated £17.2m worth of illegal medicines seized by MHRA appeared first on The Pharmacist.
Kashmik Formulation, a pharma manufacturing firm based in Ahmedabad, has announced plans to expand its production capacity, increase automation, and enhance its international footprint. The company has set a revenue target of ₹100 crore for the financial year 2025–26, following a 100 per cent year-on-year growth from ₹20 crore in FY23–24 to ₹40 crore in FY24–25.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
State workers who for decades have been pivotal in identifying U.S. cancer trends, curbing new cases, and improving screening fear their federally funded programs could be deeply cut or eliminated altogether come July. By next week, state and local programs that work on cancer are supposed to find out if their annual allocations from the Centers for Disease Control and Prevention will be renewed.
Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh
A federal vaccine advisory panel, which health secretary Robert F. Kennedy Jr. recently stacked with handpicked members , recommended on Thursday that Americans should not receive flu vaccines containing the preservative thimerosal. The votes — there were three related to the topic — reflected new members’ concerns about safety issues tied to the preservative, despite numerous studies conducted over the past quarter-century that have found no such issues.
A federal vaccine advisory panel, which health secretary Robert F. Kennedy Jr. recently stacked with handpicked members , recommended on Thursday that Americans should not receive flu vaccines containing the preservative thimerosal. The votes — there were three related to the topic — reflected new members’ concerns about safety issues tied to the preservative, despite numerous studies conducted over the past quarter-century that have found no such issues.
Just like you would create a training plan before running a marathon, preparing for test day requires planning to get across the finish line. Explore the benefits of NABP’s practice exams as you build a “training plan” for your pharmacy licensure exams. We sat down with NABP Director of Psychometrics and Research, Rob Brucia, PhD, PMP, ICE-CCP, to discuss the advantages of utilizing these practice exam tools.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
NHC Submits Comments on CMS Draft Guidance for IPAY 2028 (PDF) June 26, 2025 Mehmet Oz, MD, MBA Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services 7500 Security Boulevard Baltimore, MD 21244 RE: Draft Guidance for the Medicare Drug Price Negotiation Program: Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2028 and Manufacturer Effectuation of the Maximum Fair Price in 2026, 2027, and 2028 Dear
Explore how community pharmacies enhance care for diverse patients with disabilities, addressing barriers and improving accessibility in pharmacy services.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Search engine optimization (SEO) has evolved into one of the most critical pillars of digital success, particularly for industries like pharmaceuticals where visibility, credibility, and patient trust are non-negotiable. SEO Campaigns in pharma marketing serve as essential mechanisms to drive targeted traffic, increase awareness, and position brands as authoritative resources.
Pharmacists have been asked to help identify patients for a new study examining genetic links between GLP-1 weight loss treatment and acute pancreatitis. The Medicines and Healthcare products Regulatory Agency (MHRA), in collaboration with Genomics England, is calling for patients who have been hospitalised with acute pancreatitis while taking GLP-1 medicines – including Ozempic and […] The post Pharmacists can support study into weight loss injection side effect appeared first on The Phar
The Government of Punjab has launched the Data Intelligence and Technical Support Unit (DITSU) as part of its Yudh Nasheyan Virudh campaign to address drug and substance abuse in the state. The initiative marks a public-private collaboration with the Ananya Birla Foundation (ABF) and aims to strengthen systemic, data-driven responses to drug-related issues.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Experts from the University of East Anglia (UEA) and King’s College London have published new guidance for general practitioners (GPs) on how to manage patients who may be privately using weight loss medications such as Mounjaro or Ozempic. The guidance, published in the journal Obesity Facts , provides ten evidence-based tips to help healthcare professionals address the growing number of patients using GLP-1 receptor agonists without NHS support.
Skip to main content CONTINUE TO SITE ➞ Dont miss tomorrows biopharma industry news Let BioPharma Dives free newsletter keep you informed, straight from your inbox. Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy.
Sanofi has announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to riliprubart for the treatment of antibody-mediated rejection (AMR) in solid organ transplantation. The designation recognises the significant unmet need for patients facing AMR – an immune response that can lead to organ damage and transplant failure.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Insmed CEO Will Lewis keeps a newspaper story from 2014 framed on the wall of his office. The headline reads, “Insmed joins the biotech trash heap.” If you’re wondering, I didn’t write that story, although I could have.
Biocon Biologics (BBL), a biosimilars company and subsidiary of Biocon, has announced that Health Canada has granted a Notice of Compliance (NOC) for YESAFILI (aflibercept), a biosimilar to EYLEA (aflibercept) injection. The approval covers vial and prefilled syringe presentations, 2 mg/0.05 mL, and was granted on 26 June 2025. The company has scheduled the product’s Canadian launch for 4 July 2025.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
As the debate over drug pricing intensifies, some proposals—like the Most Favored Nation model—may sound appealing in theory, but they carry serious unintended consequences.
As part of the GOP’s megabill ambitions, Congress may be on the cusp of making the most substantial changes to Medicaid in decades. Lawmakers are considering a raft of proposals — including work requirements for non-elderly, able-bodied adults; more frequent eligibility checks for certain enrollees; and crackdowns on state financing gimmicks — designed to rein in federal Medicaid cost growth and refocus the program on the most vulnerable populations.
A recent meta-analysis reveals low persistence rates with anti-dementia drugs, highlighting factors influencing adherence and the need for standardized reporting.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer
Lower blood sugar and increased fat burning - without negatively affecting appetite or muscle mass. These are some of the most promising effects of a new potential drug treatment for people with type 2 diabetes and obesity, according to a new study published in the journal Cell by researchers from Karolinska Institutet and Stockholm University.
CSL Behring has announced a key milestone for its hereditary angioedema (HAE) therapy, garadacimab, following a positive benefit assessment by Germany’s Institute for Quality and Efficiency in Health Care (IQWiG). The agency concluded there is a “hint of considerable additional benefit” for garadacimab compared to existing HAE prophylaxis therapies, based on robust indirect comparisons using […] The post CSL Behring’s therapy for hereditary angioedema receives positive assessment in German
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content